Filter
3059
Filtered Results: 3059
Text search:
social
resistance
Featured
Recommendations
291
New Publications
860
Language
Document type
No document type
1773
Studies & Reports
516
Guidelines
363
Manuals
145
Strategic & Response Plan
136
Fact sheets
45
Training Material
37
Situation Updates
24
Infographics
6
Resource Platforms
5
Online Courses
5
Brochures
4
Countries / Regions
India
125
Global
120
Liberia
76
Western and Central Europe
76
Kenya
75
Sierra Leone
68
South Africa
65
Nepal
64
Uganda
59
Ethiopia
57
Congo, Democratic Republic of
56
Myanmar / Burma
51
Africa
47
Bangladesh
45
Tanzania
44
Latin America and the Carribbean
43
Eastern Europe
42
Rwanda
40
Nigeria
33
Zambia
32
Senegal
30
Philippines
30
Lesotho
29
Guinea
26
Ghana
26
Namibia
26
Asia
26
Malawi
25
Ukraine
25
Syria
24
Cambodia
22
South–East Asia Region
22
Cameroon
19
West and Central Africa
18
Haiti
17
Venezuela
17
South Sudan
16
Central African Republic
16
Colombia
16
Russia
16
Burkina Faso
15
Zimbabwe
15
Benin
14
Botswana
14
East and Southern Africa
14
Yemen
13
Indonesia
12
Mozambique
12
Pakistan
11
Afghanistan
10
Middle East and North Africa
10
Eastern Europe and Central Asia
10
Mali
9
Sudan
9
Argentina
9
Peru
8
Western Pacific Region
8
Tajikistan
8
Somalia
7
Iraq
7
Lebanon
7
Brazil
7
Albania
7
Vietnam
7
Jordan
6
Thailand
6
Madagascar
6
Georgia
6
USA
5
Germany
5
China
5
Eswatini/ Swaziland
5
Laos
5
Burundi
4
Sri Lanka
4
Moldova
4
Iran
4
Togo
3
Chad
3
North Macedonia
3
Serbia
3
El Salvador
3
Guatemala
3
Mexico
3
Paraguay
3
Armenia
3
Southern Africa
3
Kazakhstan
3
Turkmenistan
3
Jamaica
3
Mauritius
3
Saudi Arabia
2
Niger
2
Egypt
2
Bolivia
2
Libya
2
Bhutan
2
Timor Leste/ East Timor
2
Estonia
2
Uzbekistan
2
Uruguay
2
Japan
2
United Kingdom
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Turkey
1
Gambia
1
Singapore
1
Papua New Guinea
1
Honduras
1
Ecuador
1
Greece
1
Nicaragua
1
Chile
1
Other region
1
Fiji
1
Italy
1
Canada
1
Qatar
1
Romania
1
Lithuania
1
Kyrgyzstan
1
Belgium
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1143
Clinical Guidelines
215
Public Health
178
Key Resources
125
Women & Child Health
102
Capacity Building
44
Pharmacy & Technologies
15
Annual Report MEDBOX
3
Toolboxes
TB
328
HIV
255
COVID-19
218
AMR
179
Mental Health
168
Planetary Health
122
Ebola
97
Rapid Response
88
NTDs
88
Refugee
68
Caregiver
66
Conflict
65
Global Health Education
65
Disability
57
Natural Hazards
47
Pharmacy
37
Health Financing Toolbox
33
NCDs
33
Polio
21
Social Ethics
18
Cholera
15
Zika
11
Specific Hazards
7
South Sudan
1
Typhoon
1
Health Financing
1
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
This thematic brief accompanies the Working for Health 2022–2030 Action Plan, providing a rationale for the related actions of the Working for Health progression model (see Annex). This brief aims to inform Member States, non-state actors and other stakeholders vested in implementing the Action ...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Several Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Nether...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
Today, patient harm due to unsafe care is a large and growing global public health challenge and is one of the
leading causes of death and disability worldwide. Most of this patient harm is avoidable. As countries strive to
achieve universal health coverage and the Sustainable Development Goals, t...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
